{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:46:26Z","timestamp":1791031586110,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ijantimicag.2008.03.012","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T09:05:57Z","timestamp":1214557557000},"page":"227-232","source":"Crossref","is-referenced-by-count":19,"title":["In vitro-selected resistance to fluoroquinolones in two Brucella strains associated with mutational changes in gyrA"],"prefix":"10.1016","volume":"32","author":[{"given":"Aun","family":"Turkmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Psaroulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Christidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Chochlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darem","family":"Tabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Tselentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.03.012_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid0302.970201","article-title":"The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable","volume":"3","author":"Kaufmann","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3201\/eid0504.990411","article-title":"Potential biological weapons threats","volume":"5","author":"Kortepeter","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/clinids\/12.6.1060","article-title":"Modern chemotherapy for brucellosis in humans","volume":"12","author":"Hall","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/clinids\/5.5.821","article-title":"Human brucellosis","volume":"5","author":"Young","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14656566.6.2.201","article-title":"Effective treatments in the management of brucellosis","volume":"6","author":"Pappas","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib7","first-page":"523","article-title":"Modern chemotherapy for brucellosis in humans","volume":"13","author":"Hall","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijantimicag.2003.09.024","article-title":"In vitro antimicrobial susceptibility of Brucella species","volume":"23","author":"Baykam","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/00365540410020767","article-title":"Susceptibility of Mexican Brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis","volume":"36","author":"Lopez-Merino","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/AAC.35.4.756","article-title":"Lack of effective bactericidal activity of new quinolones against Brucella spp.","volume":"35","author":"Garcia-Rodriguez","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1128\/AAC.35.9.1925","article-title":"In vitro susceptibility of Brucella melitensis to antibiotics","volume":"35","author":"Rubinstein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.37.9.1831","article-title":"Quinolones in the treatment of human brucellosis: comparative trial of ofloxacin\u2013rifampin versus doxycycline\u2013rifampin","volume":"37","author":"Akova","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000239353","article-title":"Antibacterial activity of azithromycin against Brucella melitensis","volume":"41","author":"Qadri","year":"1995","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jac\/25.2.302","article-title":"Development of ciprofloxacin resistance in Brucella melitensis","volume":"25","author":"Al-Sibai","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/46.5.811","article-title":"Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications","volume":"46","author":"Rolain","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000088960","article-title":"Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains","volume":"51","author":"Al Dahouk","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF01971279","article-title":"Use of ciprofloxacin in the treatment of brucellosis","volume":"11","author":"Doganay","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/26.6.841","article-title":"Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis","volume":"26","author":"Lang","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0924-8579(95)00003-Q","article-title":"Brucellosis","volume":"5","author":"Lang","year":"1995","journal-title":"Int. J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib20","series-title":"Quinolone antibacterials","first-page":"421","article-title":"Clinical use of quinolones","author":"Schacht","year":"1998"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.genet.30.1.79","article-title":"Bacterial diversity based on type II DNA topoisomerase genes","volume":"30","author":"Huang","year":"1996","journal-title":"Annu Rev Genet"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2008.03.012_bib23","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1046\/j.1365-2672.92.5s1.8.x","article-title":"Mechanisms of bacterial biocide and antibiotic resistance","volume":"92","author":"Poole","year":"2002","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib25","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1128\/AAC.45.11.3140-3147.2001","article-title":"Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins","volume":"45","author":"Pan","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib26","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/AAC.38.10.2477","article-title":"Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs","volume":"38","author":"Vila","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli","volume":"34","author":"Yoshida","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib28","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/AAC.41.12.2766","article-title":"Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics","volume":"41","author":"Waters","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jac\/30.4.409","article-title":"The molecular basis of quinolone action","volume":"30","author":"Maxwell","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/42294","article-title":"Structure of the DNA breakage\u2013reunion domain of DNA gyrase","volume":"388","author":"Morais Cabral","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JB.64.4.489-499.1952","article-title":"Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics","volume":"64","author":"Szybalski","year":"1952","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0022-2836(87)90479-7","article-title":"Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase","volume":"197","author":"Swanberg","year":"1987","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/AAC.35.2.387","article-title":"4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction","volume":"35","author":"Oram","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00338386","article-title":"Quinolone-resistant mutations of the gyrA gene of Escherichia coli","volume":"211","author":"Yoshida","year":"1988","journal-title":"Mol Gen Genet"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.37.4.839","article-title":"Mechanism of action of quinolones against Escherichia coli DNA gyrase","volume":"37","author":"Yoshida","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199958002-00003","article-title":"Mechanisms of fluoroquinolone resistance: an update 1994\u20131998","volume":"58","author":"Piddock","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/44.6.735","article-title":"Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates","volume":"44","author":"Tavio","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.03.012_bib38","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1128\/AAC.46.9.3050-3053.2002","article-title":"Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family","volume":"46","author":"Braibant","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:22:22Z","timestamp":1588785742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0924857908001453"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.03.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}